Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Dr. Agarwal’s Eye Hospital Invents a New Treatment for Glaucoma


News provided by

Dr.Agarwal's Eye Hospital Limited

01 Apr, 2017, 21:09 IST

Share this article

Share toX

Share this article

Share toX

DR. AGARWAL'S EYE HOSPITAL INVENTS A NEW TREATMENT FOR GLAUCOMA Becomes the first in the world to conduct SINGLE PASS FOUR THROW (SFT) PUPILLOPLASTY providing a ray of hope for patients with Glaucoma. (PRNewsFoto/Dr. Agarwal's Eye Hospital)
DR. AGARWAL'S EYE HOSPITAL INVENTS A NEW TREATMENT FOR GLAUCOMA Becomes the first in the world to conduct SINGLE PASS FOUR THROW (SFT) PUPILLOPLASTY providing a ray of hope for patients with Glaucoma. (PRNewsFoto/Dr. Agarwal's Eye Hospital)

CHENNAI, India, April 1, 2017 /PRNewswire/ --

Becomes the first in the world to conduct SINGLE PASS FOUR THROW (SFT) PUPILLOPLASTY providing a ray of hope for patients with Glaucoma

Dr. Agarwal's Eye Hospital today announced that they have developed a new treatment for Glaucoma. A medical breakthrough, the SINGLE PASS FOUR THROW (SFT) PUPILLOPLASTY technique can be used for treating closed angle glaucoma. First in the world, SINGLE PASS FOUR THROW (SFT) PUPILLOPLASTY has shown good results in patients with both early and advanced closed angle Glaucoma.

     (Photo: http://mma.prnewswire.com/media/485382/DR__AGARWAL_S_EYE_HOSPITAL.jpg )

SINGLE PASS FOUR THROW (SFT) PUPILLOPLASTY technique is ideal for treating this closed angle glaucoma due to abnormal iris configuration and closed angle. In SFT, the iris position is corrected by releasing the iris from the angles where the fluid drains. This new method of pulling the iris (the brown tissue) from the angle from where it has been attached to the centre creates clear angles. By this method, the iris is preventing from blocking the aqueous or fluid flow inside the eye which is necessary for maintaining pressure. This method has shown better outcomes as compared to laser treatment. The method will certainly provide added advantage in treating such patients with high eye pressure due to closed angles by iris tissue.

One-of-its-kind the treatment was used successfully to save the vision of Ms. Sulochana. Aged 83, Ms. Sulochana was bought to Dr. Agarwal's Eye Hospital for an eye check-up. On diagnosis she was found to be having a pressure of around 40 mm Hg, far higher than the average pressure among glaucoma patients. In fact, her condition was such that, if the pressure was left unattended she would end up losing her vision within a week.  Initially the doctor's advised the traditional laser treatment; however that did not help in bringing down her pressure. The doctor's took the challenge and in an effort to save her vision administered SINGLE PASS FOUR THROW (SFT) PUPILLOPLASTY. Today, not only Sulochana's vision has been preserved, her pressure is also been bought down to normal and stable just like in the normal eye.

The eye resembles a CAMERA. Just as we take a photograph with the camera,  so also the eye takes a photograph of an object seen  by it.  In the camera, an object is focussed onto the film  of  the camera by a lens. This image is an inverted image and it is developed int the studio and made into an erect one. The same way,  an object is focussed by the lens of the eye onto the  film of the eye called RETINA. This image is also inverted and is made erect by the brain.

WHAT IS GLAUCOMA?

Glaucoma is an eye disease which is one of the leading causes of blindness in our country. It is fairly common in adults above the age of 35 years. A clear transparent fluid called AQUEOUS HUMOR flows through the inner eye continuously.   This inner flow can be compared to a sink with the tap turned on all the time. If the drainpipe gets blocked, water collects in the sink. Similarily in the eye there is a drainage system. Fluid is continuously coming into the eye and going out of the eye.  In GLAUCOMA, the fluid is entering the eye, but not going out because the drainage pipe of the eye is blocked. Once this happens, the fluid accumulates more and more in the eye and the pressure of the eye increases.  This increase in pressure indicates Glaucoma.

WHY DOES GLAUCOMA AFFECT VISION?

When we look at an object, the image is carried from the retina to the brain by the nerve of sight called the Optic nerve.  Once the pressure builds up in the eye as in glaucoma this pressure compresses the optic nerve and starts to  destroy it. This produces a loss of vision. Imagine if we are watching a scenery, then due to the pressure on the optic nerve after some­time the sides will not be seen and slowly a patient with glauco­ma sees only the central field of view. With the passage of time even this is lost. People seldom notice this until considerable damage has occurred. That is why glaucoma is called a thief in the night.

WHAT ARE THE SYMPTOMS OF GLAUCOMA?

  • Frequent changes of glasses, especially for near work, but none is satisfactory,
  • Rainbow coloured rings around lights
  • Blurred or foggy vision and
  • Loss of side vision
  • Keep in mind that having any of these symptoms does not neces­sarily mean that a person has glaucoma. It is better to get a check up of your eye condition if you suffer from any of these symptoms.

What is Closed angle glaucoma

GLAUCOMA is an ocular disease which is contributed by raise in eye pressure and subsequent optic nerve (nerve that connects eye to the brain) damage and visual loss. According to WHO Glaucoma is the second leading cause of blindness globally. Glaucoma, however, presents perhaps an even greater public health challenge than cataracts: because the blindness it causes is irreversible. Normal eye pressure in the general population ranges from 11 to 21mmHg.  Glaucoma is broadly divided into 2 types, namely the open angle glaucoma and the closed angle glaucoma. Closed angle glaucoma occurs due to narrow angles (the region where the eye fluid circulates to maintain pressure) and associated iris (the brown tissue) abnormality. Primary angle closure glaucoma forms almost half of all adult primary glaucomas seen in a hospital setting in India. The disease is often silent and the patient can present in late stages. However when treated in early stages, the vision can be maintained.

About Dr. Agarwal's Eye Hospital:

Dr. Agarwal's Eye Hospital a comprehensive eye hospital offering a one-stop solution for eye ailments; was started in the year 1957. Now the hospital is in its 57th   year of offering quality services in eye care. It has 15 branches in Chennai and a visible footprint in the states of Tamil Nadu, Telangana, Andhra Pradesh, Karnataka, Odisha, Andaman and Rajasthan. A tertiary eye care centre at Mauritius marks its first step towards establishing an international presence extended upto 13 branches covering the Indian Ocean region, African countries and East Asia. 

The hospital has received various awards for its inventions and services. In March 2006, Late Dr. J Agarwal, Founder-Chairman was awarded Padma Bhushan by the former President of India, Dr. APJ Abdul Kalam for his dedicated services to the poor and downtrodden. The hospital received visibility in the global arena for its inventions - Micro-Phakonit (Cataract surgery with 0.7 mm size incision) in 1999 and 'Glued Intraocular Lens Implant' performed on a 4 year old girl in January 2008 by Prof. Amar Agarwal. In February 2009, the world's first Anterior Segment Eye Transplant Surgery was performed on a 4 month old child to treat corneal disorder. In November 2013, for the first time in the World, Dr. Agarwal's Eye Hospital, Chennai transplanted a one year old donor cornea giving a new lease of sight to a 60 year old man through the new technique PDEK (Pre Descemet's Endothelial Keratoplasty).

For Further Details:
Sivagnanavel @ 9444448616                               
[email protected]
Media Contact : Jayati Meena, [email protected] , +91-9840168417, Marketing, Dr. Agarwal's Eye Hospital

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.